Hosted by University Hospital of Wales
This course is open to BCIS Members only. For details on joining BCIS visit: www.bcis.org.uk/subscribe
For BCIS Consultant Members this course is free of charge.
For BCIS Trainees and AHP Members, there is a nominal registration fee of £25.00.
State of the art 1-day course on a cornerstone of PCI strategy i.e. getting the pharmacology right.
Topics will take attendees from first contact decision-making such as pre-loading and anti-platelet choice, through the cath lab with topics to include intravenous therapy during PCI, to the longer term with sessions on DAPT duration, switching and triple therapy.
Topics covered include:
- Role of pre-loading
- Intravenous agents during PCI
- Update on emerging DAPT trial and registry data
- Anti-coagulation and anti-platelet therapy after PCI
- Optimal duration of DAPT, balancing ischaemia and bleeding
- Switching anti-platelets in convalescence
- On-going and future interventional pharmacology research
Dr Tim Kinnaird, University Hospital of Wales
Dr Richard Anderson, University Hospital of Wales
Dr Tom Johnson, Bristol Royal Infirmary
Prof Mamas Mamas, University Hospital of North Midlands